021-51111890
购物车（0）
sales@molnova.cn
KCL-286
CAS No. 1952276-71-9
KCL-286 ( —— )
产品货号. M37200 CAS No. 1952276-71-9
KCL-286 是一种口服有效的视黄酸受体 (RAR/RXR) β2 激动剂，对脊髓损伤 (SCI) 有改善作用。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥1047 | 有现货 |
|
| 5MG | ￥1591 | 有现货 |
|
| 10MG | ￥2568 | 有现货 |
|
| 25MG | ￥5224 | 有现货 |
|
| 50MG | ￥8367 | 有现货 |
|
| 100MG | ￥11093 | 有现货 |
|
| 200MG | ￥14918 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称KCL-286
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述KCL-286 是一种口服有效的视黄酸受体 (RAR/RXR) β2 激动剂，对脊髓损伤 (SCI) 有改善作用。
-
产品描述Anticancer agent 168 is an orally active retinoic acid receptor (RAR/RXR) beta2 agonist with ameliorating effects on spinal cord injury (SCI).
-
体外实验——
-
体内实验——
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点Retinoid Receptor
-
受体Retinoid Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number1952276-71-9
-
分子量334.33
-
分子式C19H14N2O4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(O)C=1C=CC(=CC1)C2=NOC(=N2)C=3OC=4C(C3)=C(C=CC4C)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Goncalves MB, et al. Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participants. Br J Clin Pharmacol. 2023 Jul 15..?
产品手册
关联产品
-
Quisinostat 2HCl
Quisinostat (JNJ-26481585) 2HCl 是一种新型第二代 HDAC 抑制剂，对 HDAC1 具有最高效力，在无细胞测定中 IC50 为 0.11 nM。
-
Mofarotene
Mofarotene (Ro-40-8757) is a small molecule compound that shows considerable antitumor activity in many cancer cell lines and can be used for the treatment of tumors and respiratory diseases.Mofarotene is a retinoic acid analog that binds to and activates retinoic acid receptors (RARs), which alters the expression of certain genes, leading to reduced cell differentiation and cell proliferation in susceptible cells.
-
HX 531
HX 531 是类视黄醇 X 受体的有效拮抗剂，IC50 值为 18 nM。
